ondansetron + dextrose

**Ondansetron + dextrose** is a parenteral pharmaceutical combination of ondansetron hydrochloride (a selective 5-HT3 receptor antagonist) and dextrose used primarily for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. Ondansetron acts by blocking the action of serotonin at 5-HT3 receptors in the central nervous system and gastrointestinal tract, inhibiting the vomiting reflex. Dextrose serves as a vehicle and energy source in the solution but does not contribute to antiemetic activity. This combination is formulated as a sterile intravenous injection, typically containing specific concentrations for administration in hospital settings, facilitating drug delivery and patient compatibility[1][2].

Brand names

ondansetron + dextrose

Other names

ondansetron hydrochloride and dextrose